Understanding high-density lipoprotein function in disease: recent advances in proteomics unravel the complexity of

Ruth Birner-Gruenberger1, Matthias Schittmayer1, Michael Holzer2

  • 1Institute of Pathology, Medical University of Graz, Graz, Austria; Omics Center Graz, BioTechMed, Graz, Austria.

Insights

High-density lipoprotein (HDL) cholesterol interventions haven't reduced cardiovascular risk. HDL proteomics reveals diverse proteins, offering potential new biomarkers for disease diagnosis and treatment effectiveness.

Area of Science:

  • Biochemistry
  • Cardiovascular Research
  • Proteomics

Background:

  • Epidemiology links HDL cholesterol and cardiovascular risk, but drug interventions targeting HDL-cholesterol haven't improved outcomes.
  • HDL particles are protein-rich, with recent advances revealing a complex proteome beyond lipid transport.
  • The proteomic complexity of HDL is increasingly recognized, with proteins involved in iron transport, immunity, and acute phase response identified.

Purpose of the Study:

  • To review recent advances in HDL proteomics and lipidomics.
  • To explore the potential of HDL proteomics for biomarker discovery.
  • To understand HDL function in health and disease through proteomic and lipidomic insights.

Main Methods:

  • Review of recent scientific literature on HDL proteomics and lipidomics.
  • Analysis of proteomic data identifying proteins associated with HDL particles.
  • Monitoring of HDL proteome changes in various disease states.

Main Results:

  • Proteomics has significantly expanded the understanding of proteins carried by HDL particles.
  • HDL particles contain proteins involved in lipid transport, iron transport, complement pathways, immune function, and acute phase response.
  • Dynamic changes in HDL subgroups are being discovered, highlighting their complexity.

Conclusions:

  • HDL proteomics offers a promising avenue for discovering novel biomarkers for disease diagnosis.
  • HDL proteomic analysis can help measure the effectiveness of current and future therapeutic strategies.
  • Understanding HDL's complex proteome is crucial for deciphering its role in health and disease.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
119
Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.5K
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
5.5K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K